Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic

September 23, 2025 updated by: Mount Sinai Hospital, Canada

Evaluating the Use of Educational Videos in a Medical Oncology Sarcoma Clinic to Improve Patient Knowledge and Satisfaction.

This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment.

Participants will watch four educational videos before their first appointment with a medical oncologist. Participants will be asked to complete surveys to assess their understanding of sarcoma and its treatment options before and after their first medical oncology clinic appointment.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Canada
    • Ontario
      • Toronto, Ontario, Canada, M5G 1X5
        • Recruiting
        • Mount Sinai Hospital
        • Contact:
        • Principal Investigator:
          • Geoffrey Watson

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Signed written and voluntary informed consent.
  2. Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma.
  3. Age ≥ 18 years.
  4. Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma.
  5. Willing/able to complete questionnaires.
  6. Able to read and write in English.

Exclusion Criteria:

  1. Inability to provide informed consent.
  2. Previously seen by a medical oncologist for their sarcoma.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Standard of Care
Other: Standard of Care
Participants in the control arm will be provided with the educational videos after their consult with the medical oncologist.
Experimental: Educational Videos
Other: Educational videos
Participants will be provided with four educational videos in clinic prior to their initial medical oncology consult.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess differences in patients' and caregivers' knowledge and perceptions of sarcoma and its treatment before and after educational intervention
Time Frame: up to 2 weeks (date when given appointment and date of first appointment)
Evaluate the changes in global responses between baseline surveys and post educational intervention surveys.
up to 2 weeks (date when given appointment and date of first appointment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess understandability and actionability of sarcoma educational videos.
Time Frame: up to 2 weeks (date when given appointment and date of first appointment)
The Patient Education Materials Assessment Tool (PEMAT) for Audiovisual Materials will be used to assess the video's understandability and actionability. The higher the score (>80%), the more understandable or actionable the material.
up to 2 weeks (date when given appointment and date of first appointment)
Assess understandability and actionability of sarcoma educational videos.
Time Frame: up to 2 weeks (date when given appointment and date of first appointment)
The Suitability Assessment of Materials (SAM) will be used for evaluation of health-related information for adults to objectively assess the suitability of these educational materials for sarcoma patients.
up to 2 weeks (date when given appointment and date of first appointment)
Assess patient's and caregivers' satisfaction with the educational videos
Time Frame: up to 2 weeks (date when given appointment and date of first appointment)
Based on responses from a post-educational intervention survey. The scores will be measured using a Likert Scale (1-5), with higher scores indicating greater satisfaction.
up to 2 weeks (date when given appointment and date of first appointment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mount Sinai Hospital, Canada

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 5, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

January 23, 2025

First Submitted That Met QC Criteria

January 28, 2025

First Posted (Actual)

February 3, 2025

Study Record Updates

Last Update Posted (Estimated)

September 25, 2025

Last Update Submitted That Met QC Criteria

September 23, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4693

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Only IPD used in the results publication will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe